Skip to main content
OpenTrials
Completed

NCT Number: NCT04755777

Provider Perspectives on Beta-lactam Therapeutic Drug Monitoring Programs in the Critically Ill

The purpose of the study is to characterize various healthcare practitioners' perspectives on implementation of beta-lactam therapeutic drug monitoring in critical care practice.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sepsis Critical Illness Disease Attributes Infections Inflammation Pathologic Processes Pathological Conditions, Signs and Symptoms Systemic Inflammatory Response Syndrome

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Royal Brisbane and Women's Hospital, Herston, Queensland, Australia

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Providers involved with beta-lactam TDM for critically ill patients

Exclusion criteria

  • None

Treatment and study plan

Primary outcomes

  1. Frequency of drug level testing recommended

    Time frame: Baseline

    Indication of how many critically ill patients treated with beta-lactams should receive TDM.

  2. Nature of drug level testing recommended

    Time frame: Baseline

    Indication of which types of critically ill patients treated with beta-lactams should receive TDM

Secondary outcomes

  1. Determinants of beta-lactam TDM implementation

    Time frame: Baseline

    List of factors associated with successful beta-lactam TDM implementation

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Official study title

Provider Perspectives on Beta-lactam Therapeutic Drug Monitoring Programs in the Critically Ill: a Multicenter Mixed-methods Study

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
Feb 16, 2021
Registry last updated
Feb 21, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.